Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.

Clinical trial NCT04866056 · TERMINATED

Trial details

NCT number: NCT04866056
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Myeloproliferative Neoplasms Myelofibrosis

Start date: 2021-09-30
Primary completion: 2022-06-10
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.